22 completed, 7 withdrawn, 5 recruiting, 5 unknown. 19 Not applicable, 8 Phase 1, 5 Phase 2, 4 Phase 4, 1 Phase 3.
Follow Port-Wine Stain: new trials by email Literature Review of Port-Wine Stain trials Research Report on Port-Wine Stain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients Pulse Dye laser, Pulse Dye Laser (PDL) pulse width stacking, Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser. - Port Wine Stains | Not applicable | Recruiting | University of Texas Southwestern Medical Center | 200 | 2026-07-01 | 2026-06-05 |
| AdvaTx Laser Treatment for Vascular Birthmarks ADVATx laser treatment - Port-wine Stains (PWS), Vascular Birthmark | Not applicable | Recruiting | Szeged University | 20 | 2025-12-10 | 2026-02-06 |
| Vbeam Pro Pulse Dye Laser for the Treatment of Vascular Conditions Vbeam Pro Laser Treatment - Rosacea, Vascular Diseases | Not applicable | Enrolling by invitation | Candela Corporation | 40 | 2025-12-10 | 2026-11-02 |
| Comparative of Sequential Application of Pulsed Dye Laser and Potassium-titanyl-phosphate Laser Treatment for Capillary Malformations Versus Single Application Pulsed dye laser (PDL), Potassium titanyl phosphate (KTP) laser, Sequential KTP + PDL laser treatment - Port-Wine Stains (Capillary Malformations) | Not applicable | Recruiting | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 30 | 2024-12-01 | 2025-06-11 |
| A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT Hemopfin+Green Light, Vehicle+Green Light - Port-wine Birthmarks, Port-Wine Stain | Phase 2 | Recruiting | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 84 | 2024-09-21 | 2026-03-03 |
| Retrospective Cohort Study on the Impact of PDL Treatment History on the Efficacy of HMME-PDT in Treating PWS Children HMME-PDT, PDL - Port-Wine Stain | Completed | Second Affiliated Hospital of Xi'an Jiaotong University | 273 | 2024-04-01 | 2025-03-13 | |
| Tolerability of 532 nm Laser Treatment of Port Wine Stains 532 nm laser treatment - Port-Wine Stain | Not applicable | Recruiting | Massachusetts General Hospital | 15 | 2023-05-01 | 2025-11-26 |
| KTP Laser vs Pulsed Dye Laser for Port-Wine Stains KTP, PDL - Port-Wine Stain | Not applicable | Unknown | Universitätsklinikum Hamburg-Eppendorf | 30 | 2023-02-01 | 2023-03-16 |
| Measure of Acceptance of chRonic Visible sKin conditionS Questionnaire - Acceptance of Visible Chronic Dermatological Disease, Disease Acceptance | Unknown | University Hospital, Tours | 250 | 2022-01-01 | 2023-10-27 | |
| Effect of Pulsed Dye Laser on Photodynamic Therapy of Port-Wine Stains PDT treatment device - Port-Wine Stain | Not applicable | Unknown | Gang Ma | 68 | 2020-10-01 | 2020-09-03 |
| A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain Hemoporfin PDT - Port-wine Stain | Phase 4 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 40 | 2020-05-27 | 2023-12-20 |
| Pilot Study to Evaluate the Effect of Multiple Passes on Port Wine Stain Treatments With the Cutera Excel V™ Laser. Cutera excel V™ Laser - Port-Wine Stain | Not applicable | Suspended | Massachusetts General Hospital | 10 | 2020-01-15 | 2019-10-15 |
| A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology Haemoblock, Placebo - Vascular Diseases, Vascular Malformation | Phase 4 | Completed | Center for Vascular Pathology, Moscow | 200 | 2020-01-01 | 2021-11-04 |
| Skin Imaging to Inform Laser Treatments Optical Coherence Tomography - Port-Wine Stain, Rosacea | Not applicable | Terminated | University of California, Irvine | 55 | 2019-09-20 | 2024-01-30 |
| Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain Hemoporfin - Port-Wine Stain | Phase 4 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 501 | 2017-08-31 | 2023-12-20 |
| A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain Hemoporfin PDT - Port-wine Stain | Phase 4 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 24 | 2017-08-02 | 2020-08-13 |
| Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations Brimonidine 0.33% gel - Capillary Malformations | Phase 3 | Terminated | The Hospital for Sick Children | 6 | 2016-06-01 | 2019-04-16 |
| The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains Pulsed dye laser (PDL) - Port Wine Stain | Not applicable | Completed | xjpfW | 80 | 2015-10-01 | 2021-03-11 |
| Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus Sirolimus, Erbium yag laser, Pulsed Dye Laser - Port-Wine Stain | Not applicable | Terminated | Erasmus Medical Center | 17 | 2014-07-01 | 2017-02-08 |
| Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study Bosentan, Pulsed dye laser (PDL) - Port-wine Stains | Phase 2 | Completed | Centre Hospitalier Universitaire de Nice | 4 | 2014-04-01 | 2018-02-05 |
Showing 20 of 45. Sign in to see all of them.
Capillary Malformations, Congenital, 1 (4) · Sturge-Weber Syndrome (3) · Hemangioma (2) · Hemangioma, Capillary (2) · Rosacea (2) · Telangiectasis (2) · Vascular Diseases (2) · Acne Vulgaris (1) · Alopecia Areata (1) · Burns (1) · Capillary Malformation-Arteriovenous Malformation (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Squamous Cell (1)
Congenital Abnormalities (45) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (45) · Skin Abnormalities (45) · Skin Diseases (45) · Skin and Connective Tissue Diseases (45) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms, Vascular Tissue (7) · Cardiovascular Diseases (6) · Hemangioma (5) · Nervous System Diseases (4) · Vascular Diseases (4) · Angiomatosis (3) · Neurocutaneous Syndromes (3) · Genetic Diseases, Inborn (2)
Lasers, Dye (8) · Lasers (3) · Lasers, Solid-State (3) · Tomography, Optical Coherence (2) · Angiogenesis Inhibitors (1) · Bosentan (1) · Brimonidine Tartrate (1) · Everolimus (1) · Gels (1) · Imiquimod (1) · Laser Therapy (1) · Ranibizumab (1) · Sirolimus (1) · Surveys and Questionnaires (1) · Talaporfin (1)
University of California, Irvine (17) · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (4) · Massachusetts General Hospital (3) · Bispebjerg Hospital (2) · University Hospital, Tours (2) · Baylor College of Medicine (1) · Candela Corporation (1) · Center for Vascular Pathology, Moscow (1) · Centre Hospitalier Universitaire de Nice (1) · Children's Hospital Medical Center, Cincinnati (1) · Erasmus Medical Center (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1) · Gang Ma (1) · Rambam Health Care Campus (1) · Second Affiliated Hospital of Xi'an Jiaotong University (1)
United States (21) · China (4) · France (3) · Denmark (2) · Spain (2) · Canada (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Russia (1)
Jining Tao (2) · John S Nelson, M.D,PhD (2) · Kristen M Kelly, M.D (2) · Adrienne Hammill, MD, PhD (1) · Alexander Plotkin, PhD (1) · Angus A Wilfong, MD (1) · Anthony DeBuys Roessingh, Dr MD PhD (1) · Benjamin J Vakoc, PhD (1) · Bernard Choi, PhD (1) · Dmitry V Romanov, MD (1) · Ekaterina M Listovskaya, BSc (1) · Elena Pope, MD (1) · Gal Shafirstein, PhD (1) · Gang Wang, Prof (1)
PMID 22244840, PMID 23455486, PMID 25007365, PMID 26916576, PMID 27235002, PMID 27272077, PMID 27320685, PMID 27885682, PMID 28095550, PMID 28213875, PMID 28541265, PMID 29082084, PMID 29110021, PMID 29566276, PMID 29611306